| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Research and development | $145.0M+39.1% | $104.2M+72.0% | $60.6M+71.7% | $35.3M+37.0% | $25.8M+235.2% | $7.7M+22.6% | $6.3M |
| General and administrative | $27.2M+200.1% | $9.1M+60.8% | $5.6M+37.4% | $4.1M+57.9% | $2.6M+38.7% | $1.9M+21.9% | $1.5M |
| Total operating expenses | $172.2M+52.0% | $113.3M+71.0% | $66.2M+68.1% | $39.4M+38.9% | $28.4M+196.7% | $9.6M+22.4% | $7.8M |
| Loss from operations | -$172.2M-52.0% | -$113.3M-71.0% | -$66.2M-68.1% | -$39.4M-38.9% | -$28.4M-196.7% | -$9.6M-22.4% | -$7.8M |
| Interest expense | -$17.1M-66.8% | -$10.3M-93.0% | -$5.3M-152.9% | -$2.1M-66.8% | -$1.3M-1051858.3% | -$120+24.5% | -$159 |
| Interest income | $12.3M+4.5% | $11.8M+51.3% | $7.8M+590.0% | $1.1M+8399.2% | $13K-83.8% | $82K-81.6% | $446K |
| Other (expense) income, net | -$4.8M-425.9% | $1.5M-39.3% | $2.5M | — | — | — | $446K |
| Net loss before income taxes | -$177.0M-58.4% | -$111.8M-75.3% | -$63.8M-58.0% | -$40.4M-36.4% | -$29.6M-212.5% | -$9.5M-28.7% | -$7.4M |
| Income taxes | — | — | — | — | — | — | $0 |
| Net loss | -$177.0M-58.4% | -$111.8M-75.3% | -$63.8M-58.0% | -$40.4M-36.4% | -$29.6M-212.5% | -$9.5M-28.7% | -$7.4M |
| Net loss per share, basic | -$3790.00-33.9% | -$2830.00-105104.5% | -$2.69-1.9% | -$2.64-19.5% | -$2.21 | — | — |
| Net loss per share, diluted | -$3790.00-33.9% | -$2830.00-105104.5% | -$2.69-1.9% | -$2.64 | — | — | — |
| Weighted average common shares outstanding, basic | 46.76B+18.5% | 39.45B+166497.4% | 23.7M+53.6% | 15.4M+15.2% | 13.4M | — | — |
| Weighted average common shares outstanding, diluted | 46.76B+18.5% | 39.45B+166497.4% | 23.7M+53.6% | 15.4M | — | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.